期刊文献+

盐酸羟考酮注射液用于腹腔镜下子宫肌瘤剔除术后镇痛的临床观察 被引量:2

Clinical observation of oxycodone hydrochloride injection for laparoscopic myomectomy postoperative analgesia
原文传递
导出
摘要 目的比较羟考酮注射液与芬太尼注射液在腹腔镜下子宫肌瘤剔除术后的镇痛效果与安全性。方法 60例行腹腔镜下子宫肌瘤剔除术患者,ASAⅠ~Ⅱ级,年龄25岁~42岁,BMI≤35 kg/m^2。依数字表法均分为两组,手术结束前15 min,O组静脉给予羟考酮注射液0.15 mg/kg,F组予芬太尼注射液0.00015 mg/kg,观察两组患者术后拔管时间、纪录术后T_1、T_2、T_3、T_4、T_5、T_6和T7VAS疼痛评分及术后24 h内恶心、呕吐、皮肤瘙痒、呼吸抑制等不良反应发生情况。结果两组患者拔管时间比较无统计学差异;O组患者VAS评分在T4、T5时点降低,O组患者术后恶心、呕吐发生例数明显减少。结论盐酸羟考酮注射液用于腹腔镜下子宫肌瘤剔除术后镇痛疗效确切,起效快,镇痛持续时间长,不良反应较少。 Objective To compare the effect and safety of oxycodone injection and fentanyl injection for postoperative analgesia in patients undergoing laparoscopic myomectomy. Methods Sisty ASAⅠ ~ Ⅱ patients,aged 25 to 42 years old,BMI≤35 kg/m^2,scheduled for laparoscopic myomectomy. All patients were divided into two groups,oxycodone 0. 15 mg/kg for group O and fentany 0. 00015 mg/kg for group F were injected intravenously 15 min before the end of surgery.The postoperative extubation time,the VAS of T_1,T_2,T_3,T_4,T_5,T_6,and T_7 and the adverse reactions of nausea,vomiting,itchy skin,respiratory depression should be observed and recorded. Results There was no significant different in extubation time; The VAS score of group O reduced in T_4 and T_5 point,patients with postoperative nausea and vomiting of group O reduced significantly. Conclusion Postoperative analgesia with oxycodone for laparoscopic myomectomy is efficacy,working fast,duration long and with less adverse reaction.
出处 《医药论坛杂志》 2018年第1期37-39,共3页 Journal of Medical Forum
关键词 羟考酮 芬太尼 腹腔镜下子宫肌瘤剔除术 术后镇痛 Oxycodone Fentanyl Laparoscopic myomectomy Postoperative analgesia
  • 相关文献

参考文献4

二级参考文献22

  • 1徐建国.疼痛药物治疗学[M].北京:人民卫生出版社,2007:264-275. 被引量:98
  • 2McNicol E,Horowicz-Mehler N,Fisk RA,et al. Management ofopioid side effects in cancer-related and chronic noncancer pain: asystematic review. J Pain, 2003,4(5) :231-256. 被引量:1
  • 3Individual variation in sensitivity to morphine and the need to switchto an alternative opioid in cancer patients. Support Care Cancer,2006,14(1):56-64. 被引量:1
  • 4Pasternak GW.Molecular biology of opioid analgesia.J Pain Symptom Manage,2005,29(5 Suppl):S2-9. 被引量:1
  • 5Andreassen TN,Klepstad P,Davies A,et al.Is oxycodone efficacy reflected in serum concentrations? A multicenter,cross sectional study in 456 adult cancer patients.J Pain Symptom Manage,2012,43(4):694-705. 被引量:1
  • 6Staahl C,Dimcevski G,Andersen SD,et al.Different effect of opioids in patients with chronic pancrdatitis:an experimental pain study.Scand J Ganstroenterol,2007,42(3):383-390. 被引量:1
  • 7Davis MP,Varga J,Dickerson D,et al.Normal-release and controlled release oxycodone:pharmacokinetics,pharmacodynamics,and controversy.Support Care Cancer,2003,11(2):84-92. 被引量:1
  • 8King SJ,Reid C,Forbes K,et al.A systematic review of oxycodone in the management of cancer pain.Palliat Med,2011,25(5):454-470. 被引量:1
  • 9King S1,Forbes K,Hanks GW.A systematic review of the use of opioid medication for those with moderate to severe cancer pain and renal impairment:a European Palliative Care Research Collaborative opioid guidelines project.Palliat Med,2011,25(5):525-552. 被引量:1
  • 10Lazzari M,Sabato AF,Caldarulo C,et al.Effectiveness and tolerability of low dose oral oxycodone/naloxone added to anticonvulsant therapy for noncancer neuropathic pain:an observational analysis.Curr Med Res Opin,2014,30(4):555-564. 被引量:1

共引文献620

同被引文献12

引证文献2

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部